It was reported that this patient on peritoneal dialysis (pd) therapy had an event of peritonitis.There were no reported allegations that the event was related to any issues with fresenius products.In additional follow-up, the patient¿s pd nurse reported that the patient had peritonitis on (b)(6) 2024.The nurse clarified that the patient was seen in the emergency room (er) on (b)(6) 2024 for a urinary tract infection (uti) characterized by abdominal pain; unrelated to dialysis/product.With respect to the reported peritonitis, it was stated that on(b)(6) 2024 the patient was seen in the (b)(6) clinic with symptoms of abdominal pain.The patient had a pd culture obtained (the same day) which grew the bacteria corynebacterium species.The patient was initiated on intra-peritoneal (ip) antibiotic therapy with vancomycin (per clinic protocol) on an outpatient basis.The patient recovered from the peritonitis event and continued pd with the same cycler.The nurse stated the patient did not have any fluid leaks or any issues with fresenius products in relation to the event.The nurse provided that the patient¿s daughter assists with pd therapy due to the patient having pre-existing dementia.It was stated the caregiver has very long fingernails and that hand hygiene was a concern.Therefore, the nurse stated the peritonitis was due to a breach in aseptic technique during the pd exchange.
|